This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vukajlovich, S W Search for Related Content PubMed PubMed Citation Articles by Vukajlovich, S W

 Previous Article  |  Next Article 

Infect Immun. 1986 September; 53(3): 480-485

Antibody-independent activation of the classical pathway of human serum complement by lipid A is restricted to re-chemotype lipopolysaccharide and purified lipid A.

ABSTRACT

Incubation of most bacterial lipopolysaccharides (LPS) with normal human sera at 37 degrees C activates the serum complement system, resulting in decreased levels of hemolytic complement. A panel of R-chemotype LPS preparations isolated from Salmonella minnesota rough mutant strains, as well as smooth wild-type LPS from S. minnesota, Escherichia coli O55-B5, Serratia marcescens, and Yersinia enterolitica, were used to examine the effect of LPS polysaccharide chain length on LPS lipid (lipid A)-dependent activation of the classical pathway of complement (CPC). To examine specific lipid A-dependent activation of the CPC, sera deficient in alternative pathway of complement activity were prepared by the removal of factor D. Absorption of normal human sera with formalinized rabbit erythrocytes was found to remove natural antibodies, factors capable of forming LPS complexes which activate the CPC, or both. By using such factor D-depleted formalinized rabbit erythrocyte-absorbed normal human sera, only isolated lipid A and Re-chemotype LPS (R595 LPS) were found to activate the CPC. Thus, the presence of the additional monosaccharide L-glycero-D-mannoheptose in the Rd2 LPS oligosaccharide chain compared with the L-glycero-D-mannoheptose-deficient Re-chemotype LPS structure is sufficient to block lipid A-dependent activation of the CPC by LPS.

This article has been cited by other articles:

• Tsukushi, Y., Kido, N., Saeki, K., Sugiyama, T., Koide, N., Mori, I., Yoshida, T., Yokochi, T. (2004). Characteristic biological activities of lipopolysaccharides from Sinorhizobium and Mesorhizobium. Innate Immunity 10: 25-31 [Abstract]  
• Wiese, A., Gutsmann, T., Seydel, U. (2003). Review: Towards antibacterial strategies: studies on the mechanisms of interaction between antibacterial peptides and model membranes. Innate Immunity 9: 67-84 [Abstract]  
• Izquierdo, L., Merino, S., Regue, M., Rodriguez, F., Tomas, J. M. (2003). Synthesis of a Klebsiella pneumoniae O-Antigen Heteropolysaccharide (O12) Requires an ABC 2 Transporter. J. Bacteriol. 185: 1634-1641 [Abstract] [Full Text]  
• Alexander, C., Rietschel, E. Th. (2001). Invited review: Bacterial lipopolysaccharides and innate immunity. Innate Immunity 7: 167-202 [Abstract]  
• Wiese, A., Grunewald, P., Schaper, K.-J., Seydel, U. (2001). Influence of acyl chain fluidity on the lipopolysaccharide-induced activation of complement. Innate Immunity 7: 147-155 [Abstract]  
• Merino, S., Altarriba, M., Izquierdo, L., Nogueras, M. M., Regue, M., Tomas, J. M. (2000). Cloning and Sequencing of the Klebsiella pneumoniae O5 wb Gene Cluster and Its Role in Pathogenesis. Infect. Immun. 68: 2435-2440 [Abstract] [Full Text]  
• David, S. A., Silverstein, R., Amura, C. R., Kielian, T., Morrison, D. C. (1999). Lipopolyamines: Novel Antiendotoxin Compounds That Reduce Mortality in Experimental Sepsis Caused by Gram-Negative Bacteria. Antimicrob. Agents Chemother. 43: 912-919 [Abstract] [Full Text]  
• Falk, M.C., Fletcher, M.A., Williams, T.J., Ching, W.M., Wu, Y., Morrison, T.K. (1996). Aggregation of serum proteins with lipopolysaccharide (LPS): characterization of the precipitable LPS-protein complex. Innate Immunity 3: 129-142 [Abstract]